IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified
M.D. Anderson Cancer Centermonoclonal_antibodyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Decitabine The First Affiliated Hospital of Soochow University | Phase 3 | B |
(+)-VINCRISTINE M.D. Anderson Cancer Center | Phase 2 | B |
Sorafenib M.D. Anderson Cancer Center | Phase 2 | B |
Clofarabine M.D. Anderson Cancer Center | Phase 2 | B |
Cytosin-Arabinosid yuejun Liu | Phase 2 | B |
View all 10 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →